In patients with chronic kidney disease (CKD), there is an unmet need for novel biomarkers
that reliably track kidney injury, demonstrate treatment-response, and predict outcomes. Here…

Chronic kidney disease (CKD) is common, with hypertension and diabetes mellitus acting as
major risk factors for its development. Cardiovascular disease is the leading cause of death …

PDE type 5 inhibitors (PDE5Is), such as sildenafil, tadalafil and vardenafil, are a class of
drugs used to prolong the physiological effects of NO/cGMP signalling in tissues through the …

Background: Acetaminophen is widely used as first-line therapy for chronic pain because of
its perceived safety and the assumption that, unlike nonsteroidal anti-inflammatory drugs, it …

… Robert W Hunter honorary consultant in renal medicine1 2, Nicola Welsh patient author3,
Tariq E Farrah specialty registrar in renal medicine1 2, Peter J Gallacher GP specialty trainee2 …

Dyslipidemia is common in chronic kidney disease (CKD). Despite statins, many patients fail
to adequately lower lipids and remain at increased risk of cardiovascular disease. Selective …

Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …

Objective ANCA-associated vasculitis (AAV) is a small vessel vasculitis that commonly presents
in the elderly. However, there are few long-term outcome data for these patients. Here, …

The benefit and utility of high-sensitivity cardiac troponin (hs-cTn) in the diagnosis of
myocardial infarction in patients with kidney impairment is unclear. Here, we describe …

Acute kidney injury (AKI) is common and associated with increased risks of cardiovascular
and chronic kidney disease. Causative molecular/physiological pathways are poorly defined. …